-
Mashup Score: 1Current Waldenström Macroglobulinemia Treatment Approaches - Patient Empowerment Network - 2 year(s) ago
Dr. Jorge Castillo discusses available Waldenström macroglobulinemi treatment approaches and their side effects.
Source: Patient Empowerment NetworkCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0New Treatment Options for Waldenstrom Macroglobulinemia - 2 year(s) ago
Waldenstrom macroglobulinemia expert shares news on promising drug combinations to treat the disease.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New Treatment Options for Waldenstrom Macroglobulinemia An expert from @DanaFarber discusses how the combination of ibrutinib and rituximab (INNOVATE Study), that have shown faster and deeper responses over time for #Waldenstrom patients: https://t.co/VRVW69DCcp #wm
-
-
Mashup Score: 1Three Ways to Partner in Your Waldenström Macroglobulinemia Care - Patient Empowerment Network - 2 year(s) ago
Three key ways that Waldenström Macroglobulinemia patients can take a more active role in their care to achieve optimal health outcomes.
Source: Patient Empowerment NetworkCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @power4patients: Three Ways to Partner in Your #Waldenström Macroglobulinemia Care https://t.co/Z6Rrsv6WRu #lymsm
-
-
Mashup Score: 0
With the introduction of multiple new effective therapeutic options for the treatment of macroglobulinemia, a structured approach to management of this rare lymphoma is currently needed. A review of phase II and III treatment trials over the past 20 years was performed, and high-quality trials are s …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
#Myeloma Paper of the Day: Really nice review article from @MorieGertz on tailoring therapy for the individual patient with #Waldenstrom macroglobulinemia in the newly diagnosed or relapsed/refractory settings: https://t.co/x9qXgdZ0G6. https://t.co/syu5UzOGRA
-
-
Mashup Score: 1The Stem Cell Transplant Daily - 2 year(s) ago
A selection of articles, blog posts, videos and photos recommended by Muzaffar Qazilbash
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet-
The latest The Stem Cell Transplant Daily! https://t.co/J5Txw5HTDx Thanks to @Myeloma_Doc @VincentRK #myeloma #waldenström
-
-
Mashup Score: 0
Waldenström macroglobulinemia/lymphoplasmacytoid lymphoma (WM/LPL) is a rare lymphoproliferative neoplasm characterized by clonally related lymphocytes, lymphoplasmacytic cells, and plasma cell proliferation. WM/LPL patients commonly present with elevated immunoglobulin, predominantly immunoglobulin …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
#Myeloma Paper of the Day: Study shows 13.3% of patients with #Waldenström macroglobulinemia/lymphoplasmacytic lymphoma may have thyroid complications that negatively impact prognosis, and may need to be incorporated into new ISSWM scoring system: https://t.co/WfewKTYeUp. https://t.co/LGH15u2L07
-
-
Mashup Score: 1How Are BTK Inhibitors Changing Waldenstrom Patients’ Outcomes? - 2 year(s) ago
Dr. Steven Treon explains how BTK inhibitors are improving treatment options for Waldenstrom macroglobulinemia patients.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
How Can BTK Inhibitors Make Life Easier for #Waldenstrom Macroglobulinemia Patients? Expert Dr. Steven Treon from @DanaFarber discusses the efficacy of Covalent BTK Inhibitors & reveals when a non-covalent BTK inhibitor may be a treatment option: https://t.co/gbrCaagMAj #wmsm
-
-
Mashup Score: 0The Stem Cell Transplant Daily - 2 year(s) ago
A selection of articles, blog posts, videos and photos recommended by Muzaffar Qazilbash
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet-
The latest The Stem Cell Transplant Daily! https://t.co/z90E2TISqR Thanks to @DrMvandenBrink @Mohty_EBMT @Myeloma_Doc #myeloma #waldenström
-
-
Mashup Score: 0
Bruton Tyrosine Kinase inhibitors (BTKi) are important treatment options in Waldenström’s macroglobulinemia (WM). Whether second-generation BTKi are associated with improved outcomes and/or better safety profile remains unclear. We did a systematic review and meta-analysis of clinical trials that re …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
#Myeloma Paper of the Day: Systematic review and meta-analysis of 1st vs. 2nd generation BTK inhibitors in #Waldenström's finds similar 18-month PFS with more grade 3/4 atrial fibrillation in 1st gen but more grade 3/4 infections and neutropenia in 2nd: https://t.co/098J3iW6A1. https://t.co/hKYYnmpT71
-
-
Mashup Score: 1The Amyloidosis Weekly - 2 year(s) ago
A selection of articles, blog posts, videos and photos recommended by Robert Z. Orlowski
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet-
The latest The Amyloidosis Weekly! https://t.co/3PF8R2iQIR Thanks to @MyAmyloidosis @lore_schr #myeloma #waldenström
-
RT @power4patients: Current #Waldenström Macroglobulinemia Treatment Approaches https://t.co/VCMcANsLTx #lymsm